x
|
Quarterly
Report Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of
1934
|
|
For
the quarterly period ended June 30,
2007.
|
o
|
Transition
Report Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of
1934
|
|
For
the transition period from to
.
|
Delaware
|
|
20-3101079
|
(State
or Other Jurisdiction of
Incorporation
or Organization)
|
|
(I.R.S.
Employer
Identification
No.)
|
Large
Accelerated Filer o
|
Accelerated
Filer o
|
Non-Accelerated
Filer x
|
Part
I.
|
Financial
Information
|
1
|
|
|
|
|
Item
1. Consolidated Financial Statements (unaudited)
|
1
|
|
|
|
|
Consolidated
Balance Sheets
|
1
|
|
|
|
|
Consolidated
Statements of Operations
|
2
|
|
|
|
|
Consolidated
Statement of Stockholders’ Equity
|
3
|
|
|
|
|
Consolidated
Statement of Cash Flows
|
4
|
|
|
|
|
Notes
to Consolidated Financial Statements
|
5
|
|
|
|
|
Item
2. Management’s Discussion and Analysis of Financial Condition and Results
of Operations
|
11
|
|
|
|
|
Item
3. Quantitative and Qualitative Disclosures About Market Risk
|
15
|
|
|
|
|
Item
4. Controls and Procedures
|
15
|
|
|
|
|
Item
4T. Controls and Procedures
|
15
|
|
|
|
Part
II.
|
Other
Information
|
`6
|
|
|
|
|
Item
1. Legal Proceedings
|
16
|
|
|
|
|
Item
1A. Risk Factors
|
16
|
|
|
|
|
Item
2. Unregistered Sales of Equity Securities and Use of
Proceeds
|
16
|
|
|
|
|
Item
3. Defaults Upon Senior Securities
|
17
|
|
|
|
|
Item
4. Submission of Matters to a Vote of Security Holders
|
17
|
|
|
|
|
Item
5. Other Information
|
17
|
|
|
|
|
Item
6. Exhibits
|
17
|
|
||
SIGNATURES
|
18
|
|
June
30, 2007
(unaudited)
|
December
31,
2006
|
|||||
ASSETS
|
|||||||
Current
assets:
|
|||||||
Cash
|
$
|
58,392
|
$
|
694,115
|
|||
Cash
and cash equivalents, held in trust
|
30,072,533
|
29,453,449
|
|||||
Prepaid
expenses
|
51,333
|
7,333
|
|||||
Total
current assets
|
30,182,258
|
30,154,897
|
|||||
Property
and equipment, net
|
3,815
|
4,901
|
|||||
Deferred
income taxes
|
13,341
|
27,932
|
|||||
Deferred
transaction costs
|
790,779
|
493,583
|
|||||
Other
assets
|
15,970
|
-
|
|||||
Total
assets
|
$
|
31,006,163
|
$
|
30,681,313
|
|||
|
|||||||
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
|||||||
|
|||||||
Current
liabilities:
|
|||||||
Accrued
expenses
|
$
|
560,967
|
$
|
624,129
|
|||
Deferred
underwriting costs
|
1,191,902
|
1,162,183
|
|||||
Notes
and accrued interest payable to related parties (net of deferred
financing
costs of $28,075)
|
274,390
|
-
|
|||||
Accrued
income taxes
|
8,364
|
118,855
|
|||||
Total
current liabilities
|
2,035,623
|
1,905,167
|
|||||
|
|||||||
Common
stock, subject to possible redemption - 764,627 shares at $7.50
per
share
|
5,738,206
|
5,738,206
|
|||||
Deferred
interest attributable to common stock subject to possible redemption
(net
of taxes)
|
276,906
|
175,747
|
|||||
|
|||||||
Stockholders’
Equity:
|
|||||||
Preferred
stock — $.0001 par value; 1,000,000 shares authorized; 0 shares issued
and
outstanding
|
-
|
-
|
|||||
Common
stock—$.0001 par value; 89,000,000 shares authorized; issued and
outstanding: 4,781,307 at June 30, 2007 and December 31, 2006 (including
764,627 shares of common stock subject to possible
redemption)
|
478
|
478
|
|||||
Additional
paid-in capital
|
22,688,787
|
22,696,946
|
|||||
Retained
earnings during the development stage
|
266,163
|
164,769
|
|||||
Total
stockholders’ equity
|
22,955,428
|
22,862,193
|
|||||
|
|||||||
Total
liabilities and stockholders’ equity
|
$
|
31,006,163
|
$
|
30,681,313
|
|||
|
|
|
|
|
|
|
|
|
|
For
the period
|
||||||
|
|
Three
|
|
Three
|
|
Six
|
|
Six
|
|
from
June 22,
|
|
|||||
|
|
Months
|
|
Months
|
|
Months
|
Months
|
2005
(inception)
|
||||||||
Ended
|
Ended
|
Ended
|
Ended
|
through
|
||||||||||||
June
30, 2007
|
June
30, 2006
|
June
30, 2007
|
June
30, 2006
|
June
30, 2007
|
||||||||||||
Operating
expenses
|
$
|
229,616
|
$
|
257,743
|
$
|
520,320
|
$
|
579,449
|
$
|
1,552,552
|
||||||
Other
income and expense
|
||||||||||||||||
Bank
interest
|
$
|
60
|
$
|
5,650
|
$
|
3,838
|
$
|
6,236
|
$
|
24,080
|
||||||
Interest
on cash and cash equivalents held in trust
|
387,127
|
353,155
|
767,938
|
570,059
|
2,100,024
|
|||||||||||
Interest
expense
|
(82,371
|
)
|
(27,362
|
)
|
(97,108
|
)
|
(27,828
|
)
|
(161,512
|
)
|
||||||
Total
other income and expense
|
304,816
|
331,443
|
674,668
|
548,467
|
1,962,592
|
|||||||||||
Income/(loss)
before provision for income taxes
|
75,200
|
73,700
|
154,348
|
(30,982
|
)
|
410,040
|
||||||||||
Provision
for income taxes
|
25,635
|
-
|
52,954
|
-
|
143,877
|
|||||||||||
Net
income/(loss)
|
$
|
49,565
|
$
|
73,700
|
$
|
101,394
|
$
|
(30,982
|
)
|
$
|
266,163
|
|||||
Deferred
interest attributable to common stock subject to possible redemption
(net
of taxes)
|
50,996
|
70,595
|
101,159
|
113,954
|
276,906
|
|||||||||||
Net
income/(loss) allocable to holders of non-redeemable common
stock
|
$
|
(1,431
|
)
|
$
|
3,105
|
$
|
235
|
$
|
(144,936
|
)
|
$
|
(10,743
|
)
|
|||
Net
income/(loss) per share - basic and diluted
|
$
|
0.01
|
$
|
0.02
|
$
|
0.02
|
$
|
(0.01
|
)
|
$
|
0.07
|
|||||
Weighted
average number of shares outstanding - basic and diluted
|
4,781,307
|
4,781,307
|
4,781,307
|
4,169,385
|
3,661,448
|
|||||||||||
Net
income/(loss) per share exclusive of shares and related interest
subject
to possible redemption - basic and diluted
|
$
|
0.00
|
$
|
0.00
|
$
|
0.00
|
$
|
(0.04
|
)
|
$
|
0.00
|
|||||
Weighted
average number of shares outstanding exclusive of shares subject
to
possible redemption -- basic and diluted
|
4,016,680
|
4,016,680
|
4,016,680
|
3,527,267
|
3,119,578
|
|||||||||||
|
|
|
|
Retained
|
|
|||||||||||
|
|
|
|
Earnings
|
|
|||||||||||
|
|
|
Additional
|
During
the
|
Total
|
|||||||||||
|
Common
Stock
|
Paid-in
|
Development
|
Stockholders'
|
||||||||||||
|
Shares
|
Amount
|
Capital
|
Stage
|
Equity
|
|||||||||||
Stock
issuance on June 23, 2005 at $.027
|
937,500
|
$
|
94
|
$
|
24,906
|
$
|
25,000
|
|||||||||
Net
loss
|
$
|
(7,743
|
)
|
(
7,743
|
)
|
|||||||||||
Balances,
at December 31, 2005
|
937,500
|
$
|
94
|
$
|
24,906
|
$
|
(7,743
|
)
|
$
|
17,257
|
||||||
Stock
issuance on January 24, 2006 at $8
|
125,000
|
12
|
999,988
|
1,000,000
|
||||||||||||
Stock
issuance on January 30, 2006 at $8
|
3,625,000
|
362
|
28,999,638
|
29,000,000
|
||||||||||||
Stock
issuance on January 30, 2006 at $8
|
75,046
|
8
|
600,360
|
600,368
|
||||||||||||
Proceeds
from issuance of option to underwriters
|
100
|
100
|
||||||||||||||
Expenses
of offerings
|
(2,145,230
|
)
|
(2,145,230
|
)
|
||||||||||||
Less:
Proceeds subject to possible redemption of 764,627 shares and
associated
deferred interest
|
(5,913,953
|
)
|
(5,913,953
|
)
|
||||||||||||
|
||||||||||||||||
Stock
based compensation
|
130,632
|
130,632
|
||||||||||||||
Officer
and director option exercise
|
18,761
|
2
|
505
|
507
|
||||||||||||
Net
income
|
172,512
|
172,512
|
||||||||||||||
Balances,
at December 31, 2006
|
4,781,307
|
$
|
478
|
$
|
22,696,946
|
$
|
164,769
|
$
|
22,862,193
|
|||||||
Increase
in deferred interest attributable to common stock subject to
possible
redemption (net of taxes)
|
(101,159
|
)
|
(101,159
|
)
|
||||||||||||
Deferred
financing costs - warrants
|
93,000
|
93,000
|
||||||||||||||
Net
income
|
101,394
|
101,394
|
||||||||||||||
Balances,
at June 30, 2007
|
4,781,307
|
$
|
478
|
$
|
22,688,787
|
$
|
266,163
|
$
|
22,955,428
|
Six
Months
Ended
June
30, 2007
|
Six
Months
Ended
June
30, 2006
|
For
the period
from
June 22,
2005
(inception)
through
June
30, 2007
|
||||||||
Cash
flows from operating activities
|
||||||||||
Net
income/(loss)
|
$
|
101,394
|
$
|
(30,982
|
)
|
$
|
266,163
|
|||
Adjustment
to reconcile net loss to net cash
|
||||||||||
used
in operating activities:
|
||||||||||
Stock
based compensation
|
$
|
-
|
$
|
130,632
|
$
|
130,632
|
||||
Amortization
of deferred financing costs
|
64,925
|
-
|
64,925
|
|||||||
Depreciation
expense
|
1,086
|
532
|
2,705
|
|||||||
Increase
in prepaid expenses
|
(44,000
|
)
|
(51,334
|
)
|
(51,333
|
)
|
||||
Increase/(decrease)
in accrued expenses
|
(80,462
|
)
|
114,253
|
101,545
|
||||||
Interest
earned on cash and cash equivalents, held in trust
|
(767,938
|
)
|
(570,059
|
)
|
(2,100,025
|
)
|
||||
Accrued
interest on deferred underwriting costs
|
29,718
|
27,362
|
93,656
|
|||||||
(Increase)/decrease
in deferred income tax asset
|
14,591
|
-
|
(13,341
|
)
|
||||||
Increase/(decrease)
in accrued income taxes
|
(110,491
|
)
|
-
|
8,363
|
||||||
Interest
income released from the trust
|
-
|
-
|
600,000
|
|||||||
Tax
payment released from the trust
|
148,854
|
-
|
148,854
|
|||||||
Net
cash used in operating activities
|
$
|
(642,323
|
)
|
$
|
(379,596
|
)
|
$
|
(747,856
|
)
|
|
Cash
flows from investing activities:
|
||||||||||
Purchases
of investments held in trust
|
$
|
(141,256,218
|
)
|
$
|
(178,921,809
|
)
|
$
|
(459,976,426
|
)
|
|
Maturity
of investments held in trust
|
141,256,218
|
150,200,446
|
431,255,063
|
|||||||
Purchase
of property and equipment
|
-
|
(6,520
|
)
|
(6,520
|
)
|
|||||
Transaction
costs
|
(270,545
|
)
|
-
|
(328,888
|
)
|
|||||
Increase
in other assets
|
(15,970
|
)
|
-
|
(15,970
|
)
|
|||||
Net
cash used in investing activities
|
$
|
(286,515
|
)
|
$
|
(28,727,883
|
)
|
$
|
(29,072,741
|
)
|
|
Cash
flows from financing activities
|
||||||||||
Gross
proceeds from public offering and private placement
|
$
|
-
|
$
|
30,600,368
|
$
|
30,600,368
|
||||
Offering
costs
|
(6,885
|
)
|
(873,356
|
)
|
(1,046,986
|
)
|
||||
Proceeds
from issuance and exercises of options
|
-
|
607
|
607
|
|||||||
Repayment
of notes payable, stockholders
|
-
|
(155,000
|
)
|
(155,000
|
)
|
|||||
Proceeds
from notes payable & warrants, stockholders
|
300,000
|
-
|
455,000
|
|||||||
Proceeds
from sale of common stock to founding stockholders
|
-
|
-
|
25,000
|
|||||||
Net
cash provided by/(used in) financing activities
|
$
|
293,115
|
$
|
29,572,619
|
$
|
29,878,989
|
||||
Net
increase/(decrease) in cash
|
(635,723
|
)
|
465,140
|
58,392
|
||||||
Cash,
beginning of period
|
694,115
|
9,608
|
-
|
|||||||
Cash,
end of period
|
$
|
58,392
|
$
|
474,748
|
$
|
58,392
|
||||
Supplemental
disclosure of cash flow information
|
||||||||||
Cash
paid for interest
|
$
|
-
|
$
|
3,177
|
$
|
3,177
|
||||
Supplemental
schedule of non-cash financing activities:
|
||||||||||
Accrual
of deferred underwriting costs
|
$
|
-
|
$
|
1,377,017
|
$
|
1,098,245
|
||||
Issuance
of warrants associated with notes to related parties
|
$
|
93,000
|
$
|
-
|
$
|
-
|
||||
Supplemental
schedule of non-cash investing activities:
|
||||||||||
Accrual
of deferred transaction costs
|
$
|
93,186
|
$
|
-
|
$
|
461,890
|
|
·
|
Weighted
average volatility factor of 0.10;
|
|
·
|
No
expected dividend payments;
|
|
·
|
Weighted
average risk-free interest rate of
5%;
|
|
·
|
A weighted
average expected life of 0.13
years.
|
·
|
the
market price of the underlying shares of common stock is lower
than the
exercise price;
|
·
|
the
holder of the warrants has not confirmed in writing that the
representative solicited the
exercise;
|
·
|
the
warrants are held in a discretionary
account;
|
·
|
the
warrants are exercised in an unsolicited transaction;
or
|
·
|
the
arrangements to pay the commission are not disclosed to warrant
holders at the time of
exercise.
|
·
|
$18.6
million in cash;
|
·
|
1,180,000
shares of common stock of Argyle (valued at approximately $9.2
million);
and
|
·
|
$1.9
million of unsecured promissory notes convertible into shares of
common
stock of the Company at a conversion price of $10 per
share.
|
·
|
$18.6
million in cash;
|
·
|
1,180,000
shares of common stock of Argyle (valued at approximately $9.2
million);
and
|
·
|
$1.9
million of unsecured promissory notes convertible into shares of
common
stock of the Company at a conversion price of $10 per
share.
|
·
|
$18.6
million in cash from the Trust Account;
|
·
|
1,180,000
shares of common stock of Argyle (valued at approximately $9.2
million);
and
|
·
|
$1.9
million of unsecured promissory notes convertible into shares of
common
stock of the Company at a conversion price of $10 per
share.
|
Exhibit
No.
|
Description
|
4.1(1)
|
Warrant
to Purchase Common Stock between the Company and Wesley
Clark
|
4.2(1)
|
Warrant
to Purchase Common Stock between the Company and John J.
Smith
|
4.3(1)
|
Warrant
to Purchase Common Stock between the Company and Bob
Marbut
|
4.4(1)
|
Warrant
to Purchase Common Stock between the Company and Ron
Chaimovski
|
4.5(1)
|
Warrant
to Purchase Common Stock between the Company and Graham
Wallis
|
4.6(1)
|
Warrant
to Purchase Common Stock between the Company and Alan
Wachtel
|
4.7(1)
|
Warrant
to Purchase Common Stock between the Company and Argyle Global
Opportunities, L.P.
|
10.1(1)
|
Note
and Warrant Acquisition Agreement between the Company and Wesley
Clark
|
10.2(1)
|
Note
and Warrant Acquisition Agreement between the Company and John
J.
Smith
|
10.3(1)
|
Note
and Warrant Acquisition Agreement between the Company and Bob
Marbut
|
10.4(1)
|
Note
and Warrant Acquisition Agreement between the Company and Ron
Chaimovski
|
10.5(1)
|
Note
and Warrant Acquisition Agreement between the Company and Graham
Wallis
|
10.6(1)
|
Note
and Warrant Acquisition Agreement between the Company and Alan
Wachtel
|
10.7(1)
|
Note
and Warrant Acquisition Agreement between the Company and Argyle
Global
Opportunities, L.P.
|
10.8(1)
|
Note
made by the Company in favor of Wesley Clark
|
10.9(1)
|
Note
made by the Company in favor of John J. Smith
|
10.10(1)
|
Note
made by the Company in favor of Bob Marbut
|
10.11(1)
|
Note
made by the Company in favor of Ron Chaimovski
|
10.12(1)
|
Note
made by the Company in favor of Graham Wallis
|
10.13(1)
|
Note
made by the Company in favor of Alan Wachtel
|
10.14(1)
|
Note
made by the Company in favor of Argyle Global Opportunities,
L.P.
|
31.1
|
Certification
of the Co-Chief Executive Officer (Principal Financial Officer)
pursuant
to Rule 13a-14(a) of the Securities Exchange Act, as
amended
|
31.2
|
Certification
of the Co-Chief Executive Officer and (Principal Executive Officer)
pursuant to Rule 13a-14(a) of the Securities Exchange Act, as
amended
|
32.1
|
Certification
of the Co-Chief Executive Officers pursuant to 18 U.S.C. 1350,
as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
.
|
(1)
|
Incorporated
by reference to the Company’s Current Report on Form 8-K dated April 16,
2007
|
(2)
|
Incorporated
by reference to the Company’s Current Report on Form 8-K dated March 14,
2007
|
|
|
|
|
ARGYLE
SECURITY ACQUISITION CORPORATION
|
|
|
|
|
August
14, 2007
|
By:
|
/s/ Bob
Marbut
|
|
Bob
Marbut
|
|
|
Co-Chief
Executive Officer
(Principal
Accounting and Financial Officer)
|
|
|
|
|
|
|
August
14, 2007
|
By:
|
/s/ Ron
Chaimovski
|
|
Ron
Chaimovski
|
|
|
Co-Chief
Executive Officer
(Principal
Executive Officer)
|
Exhibit
No.
|
Description
|
4.1(1)
|
Warrant
to Purchase Common Stock between the Company and Wesley
Clark
|
4.2(1)
|
Warrant
to Purchase Common Stock between the Company and John J.
Smith
|
4.3(1)
|
Warrant
to Purchase Common Stock between the Company and Bob
Marbut
|
4.4(1)
|
Warrant
to Purchase Common Stock between the Company and Ron
Chaimovski
|
4.5(1)
|
Warrant
to Purchase Common Stock between the Company and Graham
Wallis
|
4.6(1)
|
Warrant
to Purchase Common Stock between the Company and Alan
Wachtel
|
4.7(1)
|
Warrant
to Purchase Common Stock between the Company and Argyle Global
Opportunities, L.P.
|
10.1(1)
|
Note
and Warrant Acquisition Agreement between the Company and Wesley
Clark
|
10.2(1)
|
Note
and Warrant Acquisition Agreement between the Company and John
J.
Smith
|
10.3(1)
|
Note
and Warrant Acquisition Agreement between the Company and Bob
Marbut
|
10.4(1)
|
Note
and Warrant Acquisition Agreement between the Company and Ron
Chaimovski
|
10.5(1)
|
Note
and Warrant Acquisition Agreement between the Company and Graham
Wallis
|
10.6(1)
|
Note
and Warrant Acquisition Agreement between the Company and Alan
Wachtel
|
10.7(1)
|
Note
and Warrant Acquisition Agreement between the Company and Argyle
Global
Opportunities, L.P.
|
10.8(1)
|
Note
made by the Company in favor of Wesley Clark
|
10.9(1)
|
Note
made by the Company in favor of John J. Smith
|
10.10(1)
|
Note
made by the Company in favor of Bob Marbut
|
10.11(1)
|
Note
made by the Company in favor of Ron Chaimovski
|
10.12(1)
|
Note
made by the Company in favor of Graham Wallis
|
10.13(1)
|
Note
made by the Company in favor of Alan Wachtel
|
10.14(1)
|
Note
made by the Company in favor of Argyle Global Opportunities,
L.P.
|
31.1
|
Certification
of the Co-Chief Executive Officer (Principal Financial Officer)
pursuant
to Rule 13a-14(a) of the Securities Exchange Act, as
amended
|
31.2
|
Certification
of the Co-Chief Executive Officer and (Principal Executive
Officer)
pursuant to Rule 13a-14(a) of the Securities Exchange Act, as
amended
|
32.1
|
Certification
of the Co-Chief Executive Officers pursuant to 18 U.S.C. 1350,
as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
.
|
(1)
|
Incorporated
by reference to the Company’s Current Report on Form 8-K dated April 16,
2007
|
(2)
|
Incorporated
by reference to the Company’s Current Report on Form 8-K dated March 14,
2007
|